A Clinically Silent Resistance Phenotype That Promotes Acinetobacter baumannii Survival During Colistin Therapy
Muneer Oladipupo Yaqub, Namrata Bonde, Tuhina Maity, Ravali Arugonda, Zoe Du, Chinmai Rudra, Suman Tiwari, Roberto Jhonatan Olea‐Ozuna, Sinjini Nandy, Joseph M. Boll, Jonathan M. Monk, Nicholas Allen Dillon
The paper identifies a clinically silent resistance phenotype in Acinetobacter baumannii that allows survival during colistin therapy despite standard susceptibility testing.
bioRxiv · Jan 21, 2026 · PreprintMicrobiology